Patent and trademark issues effecting pharmaceutical laboratories, biotechs, food supplements and dietary products professionals, cosmetics companies and medical devices manufacturers is continually evolving across France and the EU. We are regularly monitoring key cases and news, to provide insights as to how this impacts business within your sector.
On June 15, 2021, a bill to modernize the fight against counterfeiting (No. 4246) was tabled in the French National Assembly. Some of the provisions, in particular its Articles 11 and 15, aim to more effectively combat counterfeit medicines. READ MORE
The Court overturned the appellate decision in part and ruled that the admissibility of an action for cancellation of a drug trademark is not conditional on the prior prohibition of the trademark by the health authorities. READ MORE